JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC.
Saved in:
| Title: | JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC. |
|---|---|
| Authors: | Li SM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.; Department of Medical Oncology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Henan, PR China., He LR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Chen JW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Zhou J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Nie RC; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Jin XH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Wang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Fu JH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.; Guangdong Esophageal Cancer Institute, Guangzhou, PR China., Wang FW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. wangfengw@sysucc.org.cn., Xie D; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. xiedan@sysucc.org.cn.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China. xiedan@sysucc.org.cn. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2020 Aug 25; Vol. 5 (1), pp. 165. Date of Electronic Publication: 2020 Aug 25. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32843613 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+SM%22">Li SM</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.; Department of Medical Oncology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Henan, PR China.<br /><searchLink fieldCode="AU" term="%22He+LR%22">He LR</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.<br /><searchLink fieldCode="AU" term="%22Chen+JW%22">Chen JW</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.<br /><searchLink fieldCode="AU" term="%22Nie+RC%22">Nie RC</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.<br /><searchLink fieldCode="AU" term="%22Jin+XH%22">Jin XH</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.<br /><searchLink fieldCode="AU" term="%22Fu+JH%22">Fu JH</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.; Guangdong Esophageal Cancer Institute, Guangzhou, PR China.<br /><searchLink fieldCode="AU" term="%22Wang+FW%22">Wang FW</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. wangfengw@sysucc.org.cn.<br /><searchLink fieldCode="AU" term="%22Xie+D%22">Xie D</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. xiedan@sysucc.org.cn.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China. xiedan@sysucc.org.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2020 Aug 25; Vol. 5 (1), pp. 165. <i>Date of Electronic Publication: </i>2020 Aug 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32843613 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41392-020-00282-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 165 Titles: – TitleFull: JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li SM – PersonEntity: Name: NameFull: He LR – PersonEntity: Name: NameFull: Chen JW – PersonEntity: Name: NameFull: Zhou J – PersonEntity: Name: NameFull: Nie RC – PersonEntity: Name: NameFull: Jin XH – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Fu JH – PersonEntity: Name: NameFull: Wang FW – PersonEntity: Name: NameFull: Xie D IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 08 Text: 2020 Aug 25 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2059-3635 Numbering: – Type: volume Value: 5 – Type: issue Value: 1 Titles: – TitleFull: Signal transduction and targeted therapy Type: main |
| ResultId | 1 |